Back
Astellas Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
ALPMY
Astellas Pharma, Inc.
Last Price:
$16.48
Seasonality Move:
3.56%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALPMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Astellas Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.15 | Buy |
| 20-day SMA: | 15.47 | Buy |
| 50-day SMA: | 15.42 | Buy |
| 200-day SMA: | 12.43 | Buy |
| 8-day EMA: | 16.14 | Buy |
| 20-day EMA: | 15.75 | Buy |
| 50-day EMA: | 15.25 | Buy |
| 200-day EMA: | 13.1 | Buy |
Astellas Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.3 | Buy |
| Relative Strength Index (14 RSI): | 61.72 | Buy |
| Chaikin Money Flow: | 45451 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.87 - 16.09) | Buy |
| Bollinger Bands (100): | (12.86 - 15.66) | Buy |
Astellas Pharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Astellas Pharma, Inc. Stock
Is Astellas Pharma, Inc. Stock a Buy?
-
Astellas Pharma, Inc. share price is 16.48 while ALPMY 8-day simple moving average is 16.15, which is a Buy signal.
-
The stock price of ALPMY is 16.48 while Astellas Pharma, Inc. 20-day SMA is 15.47, which makes it a Buy.
-
Astellas Pharma, Inc. 50-day simple moving average is 15.42 while ALPMY share price is 16.48, making it a Buy technically.
-
ALPMY stock price is 16.48 and Astellas Pharma, Inc. 200-day simple moving average is 12.43, creating a Buy signal.
ALPMY Technical Analysis vs Fundamental Analysis
Buy
60
Astellas Pharma, Inc. (ALPMY)
is a Buy
Is Astellas Pharma, Inc. a Buy or a Sell?
-
Astellas Pharma, Inc. stock is rated a BuyThe current Astellas Pharma, Inc. [ALPMY] share price is $16.48. The Score for ALPMY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Astellas Pharma, Inc. Stock Info
Market Cap:
29B
Price in USD:
16.48
Share Volume:
81.8K
Astellas Pharma, Inc. 52-Week Range
52-Week High:
17.35
52-Week Low:
8.37
Buy
60
Astellas Pharma, Inc. (ALPMY)
is a Buy
Astellas Pharma, Inc. Share Price Forecast
-
What is the Astellas Pharma, Inc. stock price today?The Astellas Pharma, Inc. stock price is 16.48 USD today.
-
Will ALPMY stock go up or go down?Astellas Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Astellas Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Astellas Pharma, Inc. is not overvalued.
Is Astellas Pharma, Inc. Stock a Buy?
-
Astellas Pharma, Inc. share price is 16.48 while ALPMY 8-day exponential moving average is 16.14, which is a Buy signal.
-
The stock price of ALPMY is 16.48 while Astellas Pharma, Inc. 20-day EMA is 15.75, which makes it a Buy.
-
Astellas Pharma, Inc. 50-day exponential moving average is 15.25 while ALPMY share price is 16.48, making it a Buy technically.
-
ALPMY stock price is 16.48 and Astellas Pharma, Inc. 200-day simple moving average is 13.10, creating a Buy signal.
Technical Analysis of Astellas Pharma, Inc.
Should I short Astellas Pharma, Inc. stock?
-
ALPMY Moving Average Covergence Divergence (MACD) indicator is 0.3, suggesting Astellas Pharma, Inc. is a Buy
-
Astellas Pharma, Inc. Relative Strength Index (RSI) is 61.72, which suggest Astellas Pharma, Inc. is overbought
-
The Bollinger Bands (25) for Astellas Pharma, Inc. is (14.87 - 16.09), which suggest Astellas Pharma, Inc. is a Buy
-
The Bollinger Bands (100) for Astellas Pharma, Inc. is (12.86 - 15.66), which suggest Astellas Pharma, Inc. is a Buy
* Astellas Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.